JAGX — Jaguar Health, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1585608 ·
Last close
$0.38
Market Cap
$1.96M
52W High
$981.75
52W Low
$0.33
ADV30
842,216
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,225,000 | 194,000 | -7,597,000 | -12,682,000 | 34,194,000 | 3,788,000 | 29,273,000 |
| Mar 2026 | 20,247,000 | 19,089,000 | 10,182,000 | 8,849,000 | 37,434,000 | 7,278,000 | 53,186,000 |
| Dec 2025 | 3,235,000 | 1,035,000 | -20,442,000 | -23,061,000 | 38,323,000 | 968,000 | 57,011,000 |
| Sep 2025 | 3,083,000 | 2,551,000 | -7,238,000 | -9,502,000 | 49,472,000 | 3,527,000 | 45,113,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,542,000
Investing CF
$-256,000
Financing CF
$12,089,000
CapEx
$-215,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1639.35
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-391,067,000
Inventory
$7,819,000
Receivables
$280,000
ST Investments
—
EBIT TTM
$-35,087,000
Pretax Income TTM
$-34,678,000
Interest Exp TTM
$699,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$27,815,000
EBITDA
$-23,193,000
Free Cash Flow
$-1,778,125
Enterprise Value
$14,444,846
Total Cash
$3,788,000
Total Debt
$16,651,000
Shares Out
5,168,300
Trailing EPS
$98.20
Book Value
$1.36
ROE
-548.8%
ROA
-38.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 11,511,000 | -45,108,000 | -53,434,000 | 38,323,000 | 57,011,000 | -17,289,000 | -23,686,000 |
| Dec 2024 | 11,689,000 | -30,831,000 | -38,492,000 | 53,425,000 | 46,931,000 | 7,285,000 | -29,384,000 |
| Dec 2023 | 9,761,000 | -33,920,000 | -41,300,000 | 50,763,000 | 45,866,000 | 4,961,000 | -33,242,000 |
| Dec 2022 | 11,956,000 | -34,415,000 | -47,454,000 | 47,500,000 | 48,808,000 | -657,000 | -33,104,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$27,815,000
NetIncome TTM
$-52,420,000
OpCashFlow TTM
—
Assets (Latest)
$34,194,000
Forward EPS
$-5.68
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PPCB | Propanc Biopharma, Inc. | $1.94M | $1.88 | — |
| XRTX | XORTX Therapeutics Inc. | $1.93M | $1.06 | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | $2.00M | $1.52 | — |
| ACUT | Accustem Sciences Inc. | $1.90M | $0.12 | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | $1.88M | $0.53 | — |
News headlines (Yahoo Finance, 1h cache)
Jaguar Health Inc (JAGX) Q3 2026 Earnings Call Highlights: Debt Cut by $10 Million as Rare ...
2026-11-17 21:01 · Yahoo
Jaguar Health Reports Third Quarter 2026 Financials
2026-11-16 14:00 · Yahoo
Jaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate Updates
2026-11-13 14:00 · Yahoo
CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
2026-11-02 14:00 · Yahoo
Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
2026-10-21 13:00 · Yahoo
Jaguar Health Provides Update Regarding Special Stock Dividend
2026-10-14 20:15 · Yahoo
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar H
2026-10-14 13:00 · Yahoo
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
2026-10-13 13:00 · Yahoo
Jaguar Health Targets Mid-2027 MVID NDA Filing as Crofelemer Intestinal Failure Program Advances
2026-10-06 14:53 · Yahoo
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
2026-10-06 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.